- Laura Ziegler
- JENNIFER HENDRICKSON
The VA Cardiovascular Conference addresses common and unique cardiovascular conditions and treatments in order to improve competency in the treatment of diseases and conditions common in the VA patient population. Staff and fellows deliver content via case studies, morbidity and mortality, research reviews and other interactive teaching modalities that engage all members of the healthcare team.
MD, DO, RN, PA, Nuclear techs, Echo Techs, Cardiology Fellows, Residents, Anesthesiologists
|Mohun Ramratnam MD, Chair||Courtney Loritz, PA||Jennifer Hendrickson, RN, Coordinator|
|Bree Terrill, BS||Laura Ziegler, MBA, BS, CNMT, Coordinator||Rochelle Goedken, BSN, RN|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
After participation in this regularly scheduled series, participants will be able to:
- List examples of strategies designed improve interdisciplinary collaboration and create a safe space for discussion in order to determine best plan of care for patients.
- Explain the scope of practice of members of the health care team.
- Contribute to discussions regarding patient care within their own scope of practice.